Neurochemical alterations in lemon shark (Negaprion brevirostris) brains in association with brevetoxin exposure

Aquatic Toxicology

Volumn 99, Issue 3, 2010, Pages 351-359

  Nam, Dong Ha ^a   Adams, Douglas H ^b   Flewelling, Leanne J ^c   Basu, Niladri ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b FISH AND WILDLIFE RESEARCH INSTITUTE   (United States)

^c FLORIDA MARINE RESEARCH INSTITUTE   (United States)

Author keywords

Algal blooms; Biotoxins; Neurochemical biomarkers; Neurotoxicology

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BREVETOXIN; CHOLINESTERASE; MERCURY; METHYLMERCURY; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SELENIUM;

ALGAL BLOOM; BIOMARKER; BRAIN; DINOFLAGELLATE; POLLUTION EXPOSURE; SHARK; TOXICOLOGY; TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DEATH; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; GILL; INTESTINE; KIDNEY PARENCHYMA; LIVER PARENCHYMA; MALE; MARINE ENVIRONMENT; MUSCLE TISSUE; NERVOUS SYSTEM INJURY; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SHARK; TISSUE LEVEL;

ALGAE; CHONDRICHTHYES; DINOPHYCEAE; KARENIA BREVIS; NEGAPRION; NEGAPRION BREVIROSTRIS;

EID: 77955560720     PISSN: 0166445X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquatox.2010.05.014     Document Type: Article

References (124)

1. Abbott B.C., Siger A., Spiegelstein M. Toxins from blooms of Gymnodinium breve. Proceedings of the First International Conference on Toxic Dinoflagellate Blooms 1975, 355-366. V.R. LoCicero (Ed.).
2. Abou-Donia M.B., Abdel-Rahman A., Goldstein L.B., Dechkovskaia A.M., Shah D.U., Bullman S.L., Khan W.A. Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats. Arch. Toxicol. 2003, 77:452-458.
3. Abraham W.M., Bourdelais A.J., Ahmed A., Serebriakov I., Baden D.G. Effects of inhaled brevetoxins in allergic airways: toxin-allergen interactions and pharmacologic intervention. Environ. Health Perspect. 2005, 113:632-637.
4. Adams D.H., Paperno R. Preliminary assessment of a nearshore nursery ground for the scalloped hammerhead off the Atlantic coast of Florida. American Fisheries Society Symposium, vol. 50 2007, 165-174.
5. Apland J.P., Adler M., Sheridan R.E. Brevetoxin depresses synaptic transmission in guinea pig hippocampal slices. Brain Res. Bull. 1993, 31:201-207.
6. Atchison W.D., Luke V.S., Narahashi T., Vogel S.M. Nerve membrane sodium channels as the target site of brevetoxins at neuromuscular junctions. Br. J. Pharmacol. 1986, 89:731-738.
7. Backer L.C., Kirkpatrick B., Fleming L.E., Cheng Y.S., Pierce R., Bean J.A., Clark R., Johnson D., Wanner A., Tamer R., Zhou Y., Baden D.G. Occupational exposure to aerosolized brevetoxins during Florida red tide events: effects on a healthy worker population. Environ. Health Perspect. 2005, 113:644-649.
8. Baden D.G. Marine food-borne dinoflagellate toxins. Int. Rev. Cytol. 1983, 82:99-150.
9. Baden D.G. Brevetoxins: unique polyether dinoflagellate toxins. FASEB J. 1989, 3:1807-1817.
10. Baden D.G., Bikhazi G., Decker S.J., Foldes F.F., Leung I. Neuromuscular blocking action of two brevetoxins from the Florida red tide organism Ptychodiscus brevis. Toxicon 1984, 22:75-84.
11. Baden D.G., Bourdelais A.J., Jacocks H., Michelliza S., Naar J. Natural and derivative brevetoxins: historical background, multiplicity, and effects. Environ. Health Perspect. 2005, 113:621-625.
12. Baden D.G., Mende T.J. Toxicity of two toxins from the Florida red tide marine dinoflagellate, Ptychodiscus brevis. Toxicon 1982, 20:457-461.
13. Baden D.G., Mende T.J., Bikhazi G., Leung I. Bronchoconstriction caused by Florida red tide toxins. Toxicon 1982, 20:929-932.
14. Bakke M.J., Horsberg T.E. Effects of algal-produced neurotoxins on metabolic activity in telencephalon, optic tectum and cerebellum of Atlantic salmon (Salmo salar). Aquat. Toxicol. 2007, 85:96-103.
15. Basu N., Scheuhammer A.M., Rouvinen-Watt K., Grochowina N., Evans R.D., O'Brien M., Chan H.M. Decreased N-methyl-d-aspartic acid (NMDA) receptor levels are associated with mercury exposure in wild and captive mink. Neurotoxicology 2007, 28:587-593.
16. Basu N., Scheuhammer A.M., Sonne C., Letcher R.J., Born E.W., Dietz R. Is dietary mercury of neurotoxicological concern to wild polar bears (Ursus maritimus)?. Environ. Toxicol. Chem. 2009, 28:133-140.
17. Basu N., Ta C.A., Waye A., Mao J., Hewitt M., Arnason J.T., Trudeau V.L. Pulp and paper mill effluents contain neuroactive substances that potentially disrupt neuroendocrine control of fish reproduction. Environ. Sci. Technol. 2009, 43:1635-1641.
18. Benson J.M., Tischler D.L., Baden D.G. Uptake, tissue distribution, and excretion of brevetoxin 3 administered to rats by intratracheal instillation. J. Toxicol. Environ. Health A 1999, 57:345-355.
19. Berman F.W., Murray T.F. Brevetoxins cause acute excitotoxicity in primary cultures of rat cerebellar granule neurons. J. Pharmacol. Exp. Ther. 1999, 290:439-444.
20. 2+ influx. J. Neurochem. 2000, 74:1443-1451.
21. Borison H.L., Ellis S., McCarthy L.E. Central respiratory and circulatory effects of Gymnodinium breve toxin in anaesthetized cats. Br. J. Pharmacol. 1980, 70:249-256.
22. Bossart G.D., Baden D.G., Ewing R.Y., Roberts B., Wright S.D. Brevetoxicosis in manatees (Trichechus manatus latirostris) from the 1996 epizootic: gross, histologic, and immunohistochemical features. Toxicol. Pathol. 1998, 26:276-282.
23. Canete E., Diogene J. Comparative study of the use of neuroblastoma cells (Neuro-2a) and neuroblastomaxglioma hybrid cells (NG108-15) for the toxic effect quantification of marine toxins. Toxicon 2008, 52:541-550.
24. Cao Z., George J., Baden D.G., Murray T.F. Brevetoxin-induced phosphorylation of Pyk2 and Src in murine neocortical neurons involves distinct signaling pathways. Brain Res. 2007, 1184:17-27.
25. Catterall W.A., Gainer M. Interaction of brevetoxin A with a new receptor site on the sodium channel. Toxicon 1985, 23:497-504.
26. Catterall W.A., Risk M. Toxin T4(6) from Ptychodiscus brevis (formerly Gymnodinium breve) enhances activation of voltage-sensitive sodium channels by veratridine. Mol. Pharmacol. 1981, 19:345-348.
27. Cattet M., Geraci J.R. Distribution and elimination of ingested brevetoxin (PbTx-3) in rats. Toxicon 1993, 31:1483-1486.
28. Cheli V., Adrover M., Blanco C., Ferrari C., Cornea A., Pitossi F., Epstein A.L., Jerusalinsky D. Knocking-down the NMDAR1 subunit in a limited amount of neurons in the rat hippocampus impairs learning. J. Neurochem. 2006, 97 Suppl. 1:68-73.
29. Cheng Y.S., Zhou Y., Irvin C.M., Pierce R.H., Naar J., Backer L.C., Fleming L.E., Kirkpatrick B., Baden D.G. Characterization of marine aerosol for assessment of human exposure to brevetoxins. Environ. Health Perspect. 2005, 113:638-643.
30. Choich J., Salierno J.D., Silbergeld E.K., Kane A.S. Altered brain activity in brevetoxin-exposed bluegill, Lepomis macrochirus, visualized using in vivo 14C 2-deoxyglucose labeling. Environ. Res. 2004, 94:192-197.
31. Churn S.B., Limbrick D., Sombati S., DeLorenzo R.J. Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neurons. J. Neurosci. 1995, 15:3200-3214.
32. Cohen J.H., Tester P.A., Forward R.B. Sublethal effects of the toxic dinoflagellate Karenia brevis on marine copepod behavior. J. Plankton Res. 2007, 29:301-315.
33. Collingridge G.L., Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. Sci. 1990, 11:290-296.
34. Colman J.R., Ramsdell J.S. The type B brevetoxin (PbTx-3) adversely affects development, cardiovascular function, and survival in Medaka (Oryzias latipes) embryos. Environ. Health Perspect. 2003, 111:1920-1925.
35. Costa R.S., Rossi M.A., Oliveira J.S. Renal hemorrhagic necrosis in choline deficiency: prevention of the lesion by treatment with alphamethyldopa. Arch. Latinoam. Nutr. 1982, 32:682-696.
36. Dravid S.M., Baden D.G., Murray T.F. Brevetoxin activation of voltage-gated sodium channels regulates Ca dynamics and ERK1/2 phosphorylation in murine neocortical neurons. J. Neurochem. 2004, 89:739-749.
37. Dravid S.M., Baden D.G., Murray T.F. Brevetoxin augments NMDA receptor signaling in murine neocortical neurons. Brain Res. 2005, 1031:30-38.
38. 2+-permeable AMPA/kainate receptor activation in murine neocortical neurons. Neurosci. Lett. 2003, 351:145-148.
39. Duysen E.G., Stribley J.A., Fry D.L., Hinrichs S.H., Lockridge O. Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Brain Res. Dev. Brain Res. 2002, 137:43-54.
40. Edwards R.A., Trainer V.L., Baden D.G. Brevetoxins bind to multiple classes of sites in rat brain synaptosomes. Brain Res. Mol. Brain Res. 1992, 14:64-70.
41. El-Nabawi A., Quesenberry M., Saito K., Silbergeld E., Vasta G., Eldefrawi A. The N-methyl-d-aspartate neurotransmitter receptor is a mammalian brain target for the dinoflagellate Pfiesteria piscicida toxin. Toxicol. Appl. Pharmacol. 2000, 169:84-93.
42. Felder C.C. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J. 1995, 9:619-625.
43. Fire S.E., Fauquier D., Flewelling L.J., Henry M., Naar J., Pierce R., Well R.S. Brevetoxin exposure in bottlenose dolphins (Tursiops truncatus) associated with Karenia brevis blooms in Sarasota Bay, Florida. Mar. Biol. 2007, 152:827-834.
44. Fleming L.E., Bean J.A., Kirkpatrick B., Cheng Y.S., Pierce R., Naar J., Nierenberg K., Backer L.C., Wanner A., Reich A., Zhou Y., Watkins S., Henry M., Zaias J., Abraham W.M., Benson J., Cassedy A., Hollenbeck J., Kirkpatrick G., Clarke T., Baden D.G. Exposure and effect assessment of aerosolized red tide toxins (brevetoxins) and asthma. Environ. Health Perspect. 2009, 117:1095-1100.
45. Fleming L.E., Kirkpatrick B., Backer L.C., Bean J.A., Wanner A., Dalpra D., Tamer R., Zaias J., Cheng Y.S., Pierce R., Naar J., Abraham W., Clark R., Zhou Y., Henry M.S., Johnson D., Van De Bogart G., Bossart G.D., Harrington M., Baden D.G. Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma. Environ. Health Perspect. 2005, 113:650-657.
46. Flewelling, L.J., 2008. Vectors of brevetoxins to marine mammals. Dissertation, University of South Florida.
47. Flewelling, L.J., Adams, D.H., Naar, J., Atwood, K.E., Granholm, A.A., O'Dea, S.N., Landsberg, J.H., 2010. Brevetoxins in sharks and rays (Chondrichthyes, Elasmobranchii) from Florida coastal waters. Mar. Biol., doi:10.1007/s00227-010-1463-z.
48. Flewelling L.J., Naar J.P., Abbott J.P., Baden D.G., Barros N.B., Bossart G.D., Bottein M.Y., Hammond D.G., Haubold E.M., Heil C.A., Henry M.S., Jacocks H.M., Leighfield T.A., Pierce R.H., Pitchford T.D., Rommel S.A., Scott P.S., Steidinger K.A., Truby E.W., Van Dolah F.M., Landsberg J.H. Brevetoxicosis: red tides and marine mammal mortalities. Nature 2005, 435:755-756.
49. Gascon S., Deogracias R., Sobrado M., Roda J.M., Renart J., Rodriguez-Pena A., Diaz-Guerra M. Transcription of the NR1 subunit of the N-methyl-d-aspartate receptor is down-regulated by excitotoxic stimulation and cerebral ischemia. J. Biol. Chem. 2005, 280:35018-35027.
50. Gawley R.E., Rein K.S., Jeglitsch G., Adams D.J., Theodorakis E.A., Tiebes J., Nicolaou K.C., Baden D.G. The relationship of brevetoxin 'length' and A-ring functionality to binding and activity in neuronal sodium channels. Chem. Biol. 1995, 2:533-541.
51. George J., Dravid S.M., Prakash A., Xie J., Peterson J., Jabba S.V., Baden D.G., Murray T.F. Sodium channel activation augments NMDA receptor function and promotes neurite outgrowth in immature cerebrocortical neurons. J. Neurosci. 2009, 29:3288-3301.
52. Hardingham G.E., Bading H. Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated. Biochim. Biophys. Acta 2002, 1600:148-153.
53. Hayes W.A. Organophosphorus pesticides. Pesticide Studies in Man 1982, 385-389. Williams & Wilkins, Baltimore. W.A. Hayes (Ed.).
54. Himori N., Moreau J.L., Martin J.R. Cerebral ischemia decreases the behavioral effects and mortality rate elicited by activation of NMDA receptors in mice. Neuropharmacology 1991, 30:1179-1186.
55. Huang J.M., Wu C.H., Baden D.G. Depolarizing action of a red-tide dinoflagellate brevetoxin on axonal membranes. J. Pharmacol. Exp. Ther. 1984, 229:615-621.
56. Husain K., Singh R., Kaushik M.P., Gupta A.K. Acute toxicity of synthetic Gymnodinium breve toxin metabolite and its analogues in mice. Ecotoxicol. Environ. Saf. 1996, 35:77-80.
57. Ishida H., Nozawa A., Nukaya H., Rhodes L., McNabb P., Holland P.T., Tsuji K. Confirmation of brevetoxin metabolism in cockle, Austrovenus stutchburyi, and greenshell mussel, Perna canaliculus, associated with New Zealand neurotoxic shellfish poisoning, by controlled exposure to Karenia brevis culture. Toxicon 2004, 43:701-712.
58. Jeglitsch G., Rein K., Baden D.G., Adams D.J. Brevetoxin-3 (PbTx-3) and its derivatives modulate single tetrodotoxin-sensitive sodium channels in rat sensory neurons. J. Pharmacol. Exp. Ther. 1998, 284:516-525.
59. Kalaitzis J.A., Chau R., Kohli G.S., Murray S.A., Neilan B.A. Biosynthesis of toxic naturally-occurring seafood contaminants. Toxicon 2009.
60. Kirkpatrick A.J., Gerhardt A., Dick J.T., McKenna M., Berges J.A. Use of the multispecies freshwater biomonitor to assess behavioral changes of Corophium volutator (Pallas, 1766) (Crustacea, Amphipoda) in response to toxicant exposure in sediment. Ecotoxicol. Environ. Saf. 2006, 64:298-303.
61. Kirkpatrick B., Currier R., Nierenberg K., Reich A., Backer L.C., Stumpf R., Fleming L., Kirkpatrick G. Florida red tide and human health: a pilot beach conditions reporting system to minimize human exposure. Sci. Total Environ. 2008, 402:1-8.
62. Klein H.H., Pich S., Lindert S., Nebendahl K., Kreuzer H. Comparative study on the enhancement of ischemic tolerance by intracoronary pretreatment with three calcium antagonists in pig hearts. Cardiovasc. Drugs Ther. 1989, 2:815-821.
63. Kobayashi H., Suzuki T., Sakamoto M., Hashimoto W., Kashiwada K., Sato I., Akahori F., Satoh T. Brain regional acetylcholinesterase activity and muscarinic acetylcholine receptors in rats after repeated administration of cholinesterase inhibitors and its withdrawal. Toxicol. Appl. Pharmacol. 2007, 219:151-161.
64. Landsberg J.H., Flewelling L.J., Naar J. Karenia brevis red tides, brevetoxins in the food web, and impacts on natural resources: decadal advancements. Harmful Algae 2009, 8:598-607.
65. LePage K.T., Baden D.G., Murray T.F. Brevetoxin derivatives act as partial agonists at neurotoxin site 5 on the voltage-gated Na+ channel. Brain Res. 2003, 959:120-127.
66. Leverone J.R., Blake N.J., Pierce R.H., Shumway S.E. Effects of the dinoflagellate Karenia brevis on larval development in three species of bivalve mollusc from Florida. Toxicon 2006, 48:75-84.
67. Manger R.L., Leja L.S., Lee S.Y., Hungerford J.M., Hokama Y., Dickey R.W., Granade H.R., Lewis R., Yasumoto T., Wekell M.M. Detection of sodium channel toxins: directed cytotoxicity assays of purified ciguatoxins, brevetoxins, saxitoxins, and seafood extracts. J. AOAC Int. 1995, 78:521-527.
68. Martin D.F., Chatterjee A.B. Isolation and characterization of a toxin from the Florida red tide organism. Nature 1969, 221:59.
69. Massensini A.R., Romano-Silva M.A., Gomez M.V. Sodium channel toxins and neurotransmitter release. Neurochem. Res. 2003, 28:1607-1611.
70. Massoulie J. The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 2002, 11:130-143.
71. McDonald B.E., Costa L.G., Murphy S.D. Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates. Toxicol. Lett. 1988, 40:47-56.
72. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 2000, 130:1007S-1015S.
73. Milian A., Nierenberg K., Fleming L.E., Bean J.A., Wanner A., Reich A., Backer L.C., Jayroe D., Kirkpatrick B. Reported respiratory symptom intensity in asthmatics during exposure to aerosolized Florida red tide toxins. J. Asthma 2007, 44:583-587.
74. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
75. Murata K., Satake M., Naoki H., Kaspar H.F., Yasumoto T. Isolation and structure of a new brevetoxin analog, brevetoxin B2, from greenshell mussels from New Zealand. Tetrahedron 1998, 54:735-742.
76. Naar J., Bourdelais A., Tomas C., Kubanek J., Whitney P.L., Flewelling L., Steidinger K., Lancaster J., Baden D.G. A competitive ELISA to detect brevetoxins from Karenia brevis (formerly Gymnodinium breve) in seawater, shellfish, and mammalian body fluid. Environ. Health Perspect. 2002, 110:179-185.
77. Naar J.P., Flewelling L.J., Lenzi A., Abbott J.P., Granholm A., Jacocks H.M., Gannon D., Henry M., Pierce R., Baden D.G., Wolny J., Landsberg J.H. Brevetoxins, like ciguatoxins, are potent ichthyotoxic neurotoxins that accumulate in fish. Toxicon 2007, 50:707-723.
78. Nam, D.H., Adams, D.H., Reyier, E.A., Basu, N., unpublished results. A multiple stressors investigation on mercury and selenium levels in lemon sharks (Negaprion brevirostris) in relation to a harmful red tide event. Mar. Environ. Res.
79. Nitsch R.M., Rossner S., Albrecht C., Mayhaus M., Enderich J., Schliebs R., Wegner M., Arendt T., von der Kammer H. Muscarinic acetylcholine receptors activate the acetylcholinesterase gene promoter. J. Physiol. Paris 1998, 92:257-264.
80. Parnetti L., Caso V., Amici S., Lanari A., Gallai V., Bottiglieri T. Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease. Clin. Exp. Hypertens. 2002, 24:501-509.
81. Peter R.E., Chang J.P., Nahorniak C.S., Omeljaniuk R.J., Sokolowska M., Shih S.H., Billard R. Interactions of catecholamines and GnRH in regulation of gonadotropin secretion in teleost fish. Recent Prog. Horm. Res. 1986, 42:513-548.
82. Pierce R., Henry M.S., Blum P.C., Hamel S.L., Kirkpatrick B., Cheng Y.S., Zhou Y., Irvin C.M., Naar J., Weidner A., Fleming L.E., Backer L.C., Baden D.G. Brevetoxin composition in water and marine aerosol along a Florida beach: assessing potential human exposure to marine biotoxins. Harmful Algae 2005, 4:965-972.
83. Pierce R.H., Henry M.S. Harmful algal toxins of the Florida red tide (Karenia brevis): natural chemical stressors in South Florida coastal ecosystems. Ecotoxicology 2008, 17:623-631.
84. Poli M.A., Mende T.J., Baden D.G. Brevetoxins, unique activators of voltage-sensitive sodium channels, bind to specific sites in rat brain synaptosomes. Mol. Pharmacol. 1986, 30:129-135.
85. Poli M.A., Templeton C.B., Thompson W.L., Hewetson J.F. Distribution and elimination of brevetoxin PbTx-3 in rats. Toxicon 1990, 28:903-910.
86. Quick J.A.J., Henderson G.E. Effects of Gymnodinium breve red tides on fishes and birds: a preliminary report on behavior, anatomy, hematology, and histopathology. Proceedings of the Gulf Coast Regional Symposium on Diseases of Aquatic Animals 1974, 85-113. R.L. Amborski, M.A. Hood, R.R. Miller (Eds.).
87. Radwan F.F., Ramsdell J.S. Brevetoxin forms covalent DNA adducts in rat lung following intratracheal exposure. Environ. Health Perspect. 2008, 116:930-936.
88. Rasool C.G., Svendsen C.N., Selkoe D.J. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease. Ann. Neurol. 1986, 20:482-488.
89. Rein K.S., Baden D.G., Lynn B., Gawley R.W. Brevetoxin B: chemical modifications, synaptosome binding, and toxicity. An unexpected conformational effect. J. Org. Chem. 1994, 59:2101-2106.
90. Reyier E.A., Adams D.H., Lowers R.H. First evidence of a high density nursery ground for the lemon shark, Negaprion brevirostris, near Cape Canaveral, Florida. Florida Scientist 2008, 71:134-148.
91. Risk M., Lin Y.Y., MacFarlane R.D., Ramanujam V.M.S., Smith L.L., Trieff N.M. Purification and chemical studies on a major toxin from Gymnodinium breve. Toxic Dinoflagellate Blooms 1979, 335-344. Elsevier/North-Holland, New York. D.L. Taylor, H.H. Seliger (Eds.).
92. Risk M., Lin Y.Y., Sadagopa Ramanujam V.M., Smith L.L., Ray S.M., Trieff N.M. High pressure liquid chromatographic separation of two major toxic compounds from Gymnodinium breve davis. J. Chromatogr. Sci. 1979, 17:400-405.
93. Risk M., Norris P.J., Coutinho-Netto J., Bradford H.F. Actions of Ptychodiscus brevis red tide toxin on metabolic and transmitter-releasing properties of synaptosomes. J. Neurochem. 1982, 39:1485-1488.
94. Rosenblum K., Futter M., Jones M., Hulme E.C., Bliss T.V. ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. J. Neurosci. 2000, 20:977-985.
95. Salmon A., Erb C., Meshorer E., Ginzberg D., Adani Y., Rabinovitz I., Amitai G., Soreq H. Muscarinic modulations of neuronal anticholinesterase responses. Chem. Biol. Interact. 2005, 157-158:105-113.
96. Sasner J.J., Ikawa M., Thurberg F., Alam M. Physiological and chemical studies on Gymnodinium breve Davis toxin. Toxicon 1972, 10:163-172.
97. Sayer A., Hu Q., Bourdelais A.J., Baden D.G., Gibson J.E. The effect of brevenal on brevetoxin-induced DNA damage in human lymphocytes. Arch. Toxicol. 2005, 79:683-688.
98. Sayer A.N., Hu Q., Bourdelais A.J., Baden D.G., Gibson J.E. The inhibition of CHO-K1-BH4 cell proliferation and induction of chromosomal aberrations by brevetoxins in vitro. Food Chem. Toxicol. 2006, 44:1082-1091.
99. Selwood A.I., Ginkel R., Wilkins A.L., Munday R., Ramsdell J.S., Jensen D.J., Cooney J.M., Miles C.O. Semisynthesis of S-desoxybrevetoxin-B2 and brevetoxin-B2, and assessment of their acute toxicities. Chem. Res. Toxicol. 2008, 21:944-950.
100. Steidinger K.A. Historical perspective on Karenia brevis red tide research in the Gulf of Mexico. Harmful Algae 2009, 8:549-561.
101. Steidinger K.A., Carlson P., Baden D.G., Rodriguez C., Seagle J. Neurotoxic shellfish poisoning due to toxin retention in the clam Chione cancellata. Harmful Algae 1998, 457-458. Xunta de Galicia and Intergovernmental Oceanographic Commission of UNESCO. B. Reguera, J. Blanco, M.L. Fernandez, T. Wyatt (Eds.).
102. Steidinger K.A., Vargo G.A., Tester P.A., Tomas C.R. Bloom dynamics and physiology of Gymnodinium breve with emphasis on the Gulf of Mexico. Physiological Ecology of Harmful Algal Blooms 1998, 133-153. Springer, Heidelberg. D.M. Anderson, A.D. Cembella, G.M. Hallegraeff (Eds.).
103. Stuart A.M., Baden D.G. Florida red tide brevetoxins and binding in fish brain synaptosomes. Aquat. Toxicol. 1988, 13:271-280.
104. Sudarsanam S., Virca G.D., March C.J., Srinivasan S. An approach to computer-aided inhibitor design: application to cathepsin L. J. Comput. Aided Mol. Des. 1992, 6:223-233.
105. Taylor P., Radic Z. The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 1994, 34:281-320.
106. Templeton C.B., Poli M.A., LeClaire R.D. Cardiorespiratory effects of brevetoxin (PbTx-2) in conscious, tethered rats. Toxicon 1989, 27:1043-1049.
107. Templeton C.B., Poli M.A., Solow R. Prophylactic and therapeutic use of an anti-brevetoxin (PbTx-2) antibody in conscious rats. Toxicon 1989, 27:1389-1395.
108. Tester P.A., Steidinger K.A. Gymnodinium breve red tide blooms: initiation, transport, and consequences of surface circulation. Limnol. Oceanogr. 1997, 42:1039-1051.
109. Tester P.A., Stumpf R.P., Steidinger K.A. Ocean color imagery: what is the minimum detection level for Gymnodinium breve blooms?. Harmful Algae 1998, 149-151. Xunta de Galicia and Intergovernmental Oceanographic Commission, UNESCO. B. Reguera, J. Blanco, M.L. Fernandez, T. Wyatt (Eds.).
110. Tester P.A., Turner J.T., Shea D. Vectorial transport of toxins from the dinoflagellate Gymnodinium breve through copepods to fish. J. Plankton Res. 2000, 22:47-61.
111. Tibbetts B.M., Baden D.G., Benson J.M. Uptake, tissue distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation. J. Toxicol. Environ. Health A 2006, 69:1325-1335.
112. Toner C.C., Stamford J.A. Sodium channel blockade unmasks two temporally distinct mechanisms of striatal dopamine release during hypoxia/hypoglycaemia in vitro. Neuroscience 1997, 81:999-1007.
113. Trainer V.L., Baden D.G. High affinity binding of red tide neurotoxins to marine mammal brain. Aquat. Toxicol. 1999, 46:139-148.
114. Trudeau V.L. Neuroendocrine regulation of gonadotrophin II release and gonadal growth in the goldfish, Carassius auratus. Rev. Reprod. 1997, 2:55-68.
115. Tsai M.C., Chen M.L. Effects of brevetoxin-B on motor nerve terminals of mouse skeletal muscle. Br. J. Pharmacol. 1991, 103:1126-1128.
116. Walsh C.J., Leggett S.R., Strohbehn K., Pierce R.H., Sleasman J.W. Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat). Mar. Drugs 2008, 6:291-307.
117. Walsh C.J., Luer C.A., Noyes D.R. Effects of environmental stressors on lymphocyte proliferation in Florida manatees, Trichechus manatus latirostris. Vet. Immunol. Immunopathol. 2005, 103:247-256.
118. Washburn B.S., Baden D.G., Gassman N.J., Walsh P.J. Brevetoxin: tissue distribution and effect on cytochrome P450 enzymes in fish. Toxicon 1994, 32:799-805.
119. Washburn B.S., Vines C.A., Baden D.G., Hinton D.E., Walsh P.J. Differential effects of brevetoxin and β-naphthoflavone on xenobiotic metabolizing enzymes in striped bass (Morone saxatilis). Aquat. Toxicol. 1996, 35:1-10.
120. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu. Rev. Pharmacol. Toxicol. 2004, 44:423-450.
121. Wolny J., Scott P., Brooks C., Beadle H., Brame J., Browning B., Faltin E., Snider D., Tustison J. Monitoring the 2007 Florida east coast Karenia brevis red tide and NSP outbreak. 11th International Conference on Shellfish Restoration 2008, 75-76.
122. Wu C.H., Huang J.M., Vogel S.M., Luke V.S., Atchison W.D., Narahashi T. Actions of Ptychodiscus brevis toxins on nerve and muscle membranes. Toxicon 1985, 23:481-487.
123. Yu X.M. The role of intracellular sodium in the regulation of NMDA-receptor-mediated channel activity and toxicity. Mol. Neurobiol. 2006, 33:63-80.
124. Yuhi T., Wada A., Yamamoto R., Urabe M., Niina H., Izumi F., Yanagita T. Characterization of [3H]brevetoxin binding to voltage-dependent sodium channels in adrenal medullary cells. Naunyn Schmiedebergs Arch. Pharmacol. 1994, 350:209-212.